BiCNU

In some countries, this medicine may only be approved for veterinary use.

In the US, BiCNU (carmustine systemic) is a member of the drug class alkylating agents and is used to treat Brain Tumor, Glioblastoma Multiforme, Hodgkin's Lymphoma, Malignant Glioma, Multiple Myeloma and Non-Hodgkin's Lymphoma.

US matches:

• BiCNU

Ingredient matches for BiCNU

Carmustine

Carmustine is reported as an ingredient of BiCNU in the following countries:

• Algeria


• Argentina


• Australia


• Bahrain


• Bosnia & Herzegowina


• Canada


• Chile


• Colombia


• Cote D'ivoire


• Czech Republic


• Egypt


• France


• Greece


• Hong Kong


• Hungary


• Iran


• Iraq


• Ireland


• Jordan


• Kuwait


• Lebanon


• New Zealand


• Oman


• Peru


• Philippines


• Qatar


• Saudi Arabia


• Singapore


• Slovakia


• South Africa


• Syria


• Taiwan


• Tunisia


• United Arab Emirates


• United Kingdom


• United States


• Yemen

International Drug Name Search